Target
Docetaxel
8 abstracts
Abstract
Neoadjuvant sintilimab and platinum-doublet chemotherapy followed by transoral robotic surgery for HPV-associated resectable oropharyngeal cancer: Single-arm, phase II trial.Org: Sun Yat-sen University Cancer Center, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Guangzhou, China, Gansu Provincial Cancer Hospital,
Abstract
Prospective randomized multicenter phase III trial comparing perioperative chemotherapy (FLOT protocol) to neoadjuvant chemoradiation (CROSS protocol) in patients with adenocarcinoma of the esophagus (ESOPEC trial).Org: University of Bielefeld, Medical University of Graz, Department of Radiation Oncology, University of Leipzig Medical Center, Comprehensive Cancer Center Central Germany,
Abstract
A phase II randomized trial evaluating consolidative nivolumab in locally advanced non-small cell lung cancer post neoadjuvant chemotherapy plus nivolumab and concurrent chemoradiotherapy (GASTO-1091).Org: Department of Radiation Oncology, State Key Laboratory of Oncology in South China, Guangdong Provincial Clinical Research Center for Cancer, Sun Yat-sen University Cancer Center, The First People's Hospital of Foshan,
Abstract
NeoTRACT: Phase II trial of neoadjuvant tumor infiltrating lymphocyte- and response-adapted chemoimmunotherapy for triple-negative breast cancer (TNBC).Org: University of Kansas Medical Center, ZAS Hospitals, Department of Pathology, Brigham and Women's Hospital, Harvard Medical School, University of Kansas Cancer Center,
Abstract
RAGE inhibition to decrease cancer therapy related cardiotoxicity in women with early breast cancer (RAGE).Org: Medstar Georgetown University Hospital-Lombardi Comprehensive Cancer Center, Lombardi Cancer Center Georgetown University, Regional Cancer Care Associates, Cantex Pharmaceuticals, Georgetown University Medical Center,
Abstract
Chemotherapy induced peripheral neuropathy (CIPN) due to paclitaxel versus docetaxel in patients with early-stage breast cancer receiving taxane therapy: SWOG S1714.Org: Fred Hutchinson Cancer Research Center, University of Michigan, Lewis Cancer & Research Pavilion at St. Joseph's Candler/GA NCORP, Bon Secours Cancer Institute at St. Francis, Cancer & Hematology Centers of Western Michigan,
Abstract
Immuno-chemotherapy as single treatment modality for larynx preservation (ICoLP): Co-primary endpoints and safety results.Org: The University of Texas MD Anderson Cancer Center, MD Anderson Cancer Center, University of Texas MD Anderson Cancer Center, Thoracic/Head and Neck Medical Oncology, Houston, TX,
Abstract
The role of volume of disease for treatment selection in patients with metastatic castration sensitive prostate cancer (mCSPC): A living meta-analysis.Org: Mayo Clinic, Dana-Farber Cancer Institute, Mayo Clinic Department of Digital Health, Dow Medical College, Karachi, Pakistan, Mayo Clinic Department of Pediatric and Adolescent Medicine,